Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details